METHOD FOR PREDICTION OF THE RISK OF DEVELOPING FETAL GROWTH RETARDATION SYNDROME IN WOMEN WITHOUT PRE-EXISTING FAMILY HISTORY USING MOLECULAR GENETIC DATA Russian patent published in 2020 - IPC G01N33/50 C12Q1/6827 

FIELD: medicine.

SUBSTANCE: invention refers to medicine and aims at prediction of the risk of fetal growth retardation syndrome in women without a burdened family history. DNA is recovered from peripheral venous blood, analyzed polymorphisms rs2234693 and rs9340799 of the estrogen receptor gene ESR1, prediction of a high risk of developing fetal growth retardation syndrome when observing a TG haplotype of polymorphous loci rs2234693-rs9340799 of the ESR1 estrogen receptor gene in females of Russian nationality, native of the Central Black Earth Region.

EFFECT: invention provides the criteria for assessing the risk of developing fetal growth retardation syndrome in Russian women who are natives of the Central Black Earth Region, who have no burdened family history of intrauterine growth retardation.

1 cl, 2 dwg, 1 tbl, 4 ex